High bone fracture risk in a large modern cohort of liver transplant recipients
- PMID: 39331313
- PMCID: PMC11794375
- DOI: 10.1007/s11739-024-03767-5
High bone fracture risk in a large modern cohort of liver transplant recipients
Abstract
Liver transplantation (LT) has historically been associated with a high prevalence of osteoporosis, but most of the available data date back to late 1990s-early 2000s with limited sample size. Our aim was to assess the prevalence of bone fragility fractures and contributing factors in a large modern cohort of liver transplant recipients. Retrospective study of 429 consecutive patients receiving liver transplantation from 1/1/2010 to 31/12/2015. Final cohort included 366 patients. Electronic radiological images (lateral views of spine X-rays or Scout CT abdominal scans) performed within 6 months from LT, were blinded reviewed to screen for morphometric vertebral fractures. Symptomatic clinical fragility fractures were recorded from the medical records. Patients with fragility fractures in the cohort were 155/366 (42.3%), with no significant differences between sexes. Most sustained vertebral fractures (145/155, 93.5%), mild or moderate wedges, with severe fractures more frequently observed in women. Multiple vertebral fractures were common (41.3%). Fracture rates were similar across different etiologies of cirrhosis and independent of diabetes or glucocorticoids exposure. Kidney function was significantly worse in women with fractures. Independently of age, sex, alcohol use, eGFR, and etiology of liver disease, low BMI was significantly associated with an increased risk for fractures (adjusted OR 1.058, 95%CI 1.001-1.118, P = 0.046). Our study shows a considerable fracture burden in a large and modern cohort of liver transplant recipients. Given the very high prevalence of bone fractures, a metabolic bone disease screening should be implemented in patients awaiting liver transplantation.
Keywords: Cirrhosis; Liver failure; Liver transplantation; Osteoporosis; Vertebral fractures.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflicts of interest: The authors declare they have no conflict of interest. Human and animal rights statement and Informed Consent: Informed consent was waived due to the retrospective nature of the study.
Figures
Similar articles
-
No association between BMD and prevalent vertebral fractures in liver transplant recipients at time of screening before transplantation.J Clin Endocrinol Metab. 2014 Oct;99(10):3677-85. doi: 10.1210/jc.2014-1469. Epub 2014 Jul 24. J Clin Endocrinol Metab. 2014. PMID: 25057874
-
Incidence of vertebral fractures in the first three months after orthotopic liver transplantation.Eur J Gastroenterol Hepatol. 2000 Aug;12(8):931-5. doi: 10.1097/00042737-200012080-00013. Eur J Gastroenterol Hepatol. 2000. PMID: 10958221
-
Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatment.J Bone Miner Res. 2014 Aug;29(8):1763-9. doi: 10.1002/jbmr.2214. J Bone Miner Res. 2014. PMID: 24644003
-
Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.Syst Rev. 2023 Mar 21;12(1):51. doi: 10.1186/s13643-023-02181-w. Syst Rev. 2023. PMID: 36945065 Free PMC article.
-
A systematic review and meta-analysis on the incidence of osteoporosis and fractures after liver transplant.Transpl Int. 2021 Jun;34(6):1032-1043. doi: 10.1111/tri.13863. Epub 2021 May 19. Transpl Int. 2021. PMID: 33835638
Cited by
-
Clinical Utility of Trabecular Bone Score in Gastroenterology: A Narrative Review.Biomedicines. 2025 May 29;13(6):1331. doi: 10.3390/biomedicines13061331. Biomedicines. 2025. PMID: 40564050 Free PMC article. Review.
-
Side Effects of Immunosuppressant Drugs After Liver Transplant.Pharmaceuticals (Basel). 2025 Feb 27;18(3):342. doi: 10.3390/ph18030342. Pharmaceuticals (Basel). 2025. PMID: 40143120 Free PMC article. Review.
References
-
- Guañabens N, Parés A (2010) Liver and bone. Arch Biochem Biophys 503(1):84–94. 10.1016/j.abb.2010.05.030. (Epub 2010 Jun 9 PMID: 20537977) - PubMed
-
- Compston JE, McClung MR, Leslie WD (2019) Osteoporosis Lancet 393(10169):364–376. 10.1016/S0140-6736(18)32112-3. (PMID: 30696576) - PubMed
-
- Nuti R, Brandi ML, Checchia G, Di Munno O, Dominguez L, Falaschi P, Fiore CE, Iolascon G, Maggi S, Michieli R, Migliaccio S, Minisola S, Rossini M, Sessa G, Tarantino U, Toselli A, Isaia GC (2019) Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med 14(1):85–102. 10.1007/s11739-018-1874-2. Epub 2018 Jun 13. PMID: 29948835; PMCID: PMC6329834. - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous